Identifies key anti-inflammatory compounds in honey-processed Ephedrae Herba, suggesting a novel strategy for bioactive compound discovery.
Ephedrae Herba (EH), a traditional Chinese medicine long used for asthma treatment, is commonly processed with honey to yield honey-processed Ephedrae Herba (HEH), a form believed to enhance therapeutic efficacy. This study developed an integrated approach combining bioactivity evaluation, mass spectrometry, and machine learning to identify the key anti-inflammatory constituents of HEH. HEH extract was separated into five fractions using column chromatography. Anti-inflammatory activity was assessed in lipopolysaccharides (LPS)-induced RAW 264.7 macrophages, with Fr C demonstrating the strongest inhibition of nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 production. UPLC-quadrupole time-of-flight mass spectrometer (Q-TOF-MS) and Global Natural Products Social Molecular Networking (GNPS)-based molecular networking enabled the tentative identification of 150 compounds in Fr C. Using the machine learning model (InflamNat) and molecular docking, 14 compounds were predicted to show anti-inflammatory potential. Four high-priority compounds were selected based on docking scores and experimentally validated. Each significantly suppressed the release of NO and pro-inflammatory cytokines (p < 0.01). These results indicate that the enhanced anti-inflammatory activity of HEH is attributable to its flavonoid and alkaloid components, providing a chemical basis for its traditional use in inflammatory diseases such as asthma. Our findings not only clarify the material basis of HEH's but also demonstrate a powerful analytical strategy for rapidly identifying bioactive compounds in processed herbal medicines.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: